Search Result
| 1 |
Mechanistic insight into the cholinergic, muscarinic and
antagonistic effects of Khat (Catha edulis) on native
nicotinic acetylcholine receptors
Abstract |
 Fulltext
|
| 2 |
Exploring the mechanism of action of Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis based on network pharmacology and molecular docking
Abstract |
Fulltext
|
| 3 |
Network pharmacology and molecular docking studies on the mechanism of action of moist exposed burn ointment for treatment of diabetic foot ulcer
Abstract |
Fulltext
|
| 4 |
Investigating the underlying mechanisms of Wuling powder in the management of hyperuricemia based on network pharmacology and molecular docking
Abstract |
Fulltext
|
| 5 |
Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: A structural approach
Abstract |
Fulltext
|
| 6 |
Molecular docking, ADMET, molecular dynamic simulation, synthesis, and preliminary antiproliferative study of 1,2,4-thiadiazole derivatives as possible histone deacetylase inhibitors
Abstract |
Fulltext
|
| 7 |
Investigation of the potential pharmacological mechanism of action of Danhong injection against chronic heart failure using a network pharmacology-based approach
Abstract |
Fulltext
|
| 8 |
A network pharmacology-based investigation on the underlying mechanism of Huqian Wan against osteoporosis
Abstract |
Fulltext
|
| 9 |
Network pharmacology integrated molecular docking demonstrates the therapeutic mode of Panax ginseng against ovarian cancer
Abstract |
Fulltext
|
| 10 |
Cytotoxic and alpha amylase-inhibitory metabolites from Tagetes minuta: In vitro evaluation and docking studies
Abstract |
Fulltext
|
| 11 |
Elucidation of the active components and molecular mechanisms of action of Xiaoyin granules (XYG) against psoriasis and its synergism with acitretin using network pharmacology and molecular docking
Abstract |
Fulltext
|
| 12 |
Investigation of potential targets and mechanisms of action of Bailing tablets on vitiligo based on network pharmacology and molecular docking
Abstract |
Fulltext
|
| 13 |
In silico studies-assisted design, synthesis, and discovery of biologically active isatin derivatives
Abstract |
Fulltext
|
| 14 |
Bioinformatics and experimental validation of mechanisms underlying lenvatinib therapy for hepatocellular carcinoma
Abstract |
Fulltext
|
| 15 |
Molecular docking and molecular dynamics simulation studies on the effect of baicalein on breast and ovarian cancers
Abstract |
Fulltext
|
| 16 |
Identification of potential biomarkers and candidate small-molecule drugs for heart failure via comprehensive gene microarray analysis
Abstract |
Fulltext
|
| 17 |
Systematic elucidation of the traditional Chinese medicine prescription Danxiong particles via network pharmacology and molecular docking
Abstract |
Fulltext
|
| 18 |
Synthesis, antimalarial activity assay and molecular docking study of N-substituted chloro-pyrazolines
Abstract |
Fulltext
|
| 19 |
Network pharmacology and GEO chip-based elucidation of mechanisms underlying the use of Yi Tieqing for prevention and treatment of postoperative nausea and vomiting
Abstract |
Fulltext
|
| 20 |
Elucidation of mechanisms of action of Wei-Sheng-Fang-Yi-Bao-Dan in the treatment of COVID-19 and depression using network pharmacology and molecular docking
Abstract |
Fulltext
|
| 21 |
Effects of anti-cyclooxygenases (COX-1 and COX-2), structure activity relationship, molecular docking and in silico ADMET of some synthesized chalcones
Abstract |
Fulltext
|
| 22 |
Design and characterization of core scaffold pyrazolone fused thiazolidinone analogues as potent anticancer agents
Abstract |
Fulltext
|
| 23 |
Anti-cancer molecular mechanism of Actinidia chinensis Planch in gastric cancer based on network pharmacology and molecular docking
Abstract |
Fulltext
|
| 24 |
Chemical constituents of Combretum dolichopetalum: Characterization, antitrypanosomal activities and molecular docking studies
Abstract |
Fulltext
|
| 25 |
Evaluation of antioxidant activation by potential nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/Keap1 complex inhibitors
Abstract |
Fulltext
|
| 26 |
Design, synthesis and cytotoxic evaluation of 2-amino-4-aryl-6-substituted pyridine-3,5-dicarbonitrile derivatives
Abstract |
Fulltext
|
| 27 |
Molecular docking study on columbin isolated from Tinospora cordifolia as a cholinesterase inhibitor
Abstract |
Fulltext
|
| 28 |
Exploring the action of new FimH inhibitors against CTX–15 enzyme by enzoinformatics approach: A plausible arsenal against drug-resistant uropathogenic bacterial strains
Abstract |
Fulltext
|
| 29 |
Determination of the anti-polo like kinase 1 potential of novel derivatives of thiophene using oncoinformatics approach
Abstract |
Fulltext
|
| 30 |
Investigation into the prophylactic and therapeutic activity of coenzyme Q10 against COVID-19
Abstract |
Fulltext
|
| 31 |
Aspirin-aromatic amino acid conjugates as selective Cox-2 inhibitors: A docking study
Abstract |
Fulltext
|
| 32 |
Molecular modelling studies and synthesis of novel quinoxaline derivatives with potential inhibitory effect on GSK-3β
Abstract |
Fulltext
|
| 33 |
Computational design of phosphoinositide 3-kinase gamma (PI3Kg) inhibitors as a newer therapy for rheumatoid arthritis
Abstract |
Fulltext
|
| 34 |
Mechanism of pharmacological effect of Angelica essential oil on anxiety based on network pharmacology and molecular docking
Abstract |
Fulltext
|
| 35 |
Molecular docking and dynamic simulation study to explore quercetin as a multi-potent candidate against gliomas
Abstract |
Fulltext
|
| 36 |
Analysis of the effect of the Chinese herbal pair, Semen Persicae–Carthami Flos, on psoriasis using network pharmacology
Abstract |
Fulltext
|
| 37 |
Identification of key bioactive anti-migraine constituents of Asari radix et rhizoma using network pharmacology and nitroglycerin-induced migraine rat model
Abstract |
Fulltext
|
| 38 |
Identification of the anti-COVID-19 mechanism of action of Han-Shi Blocking Lung using network pharmacology-integrated molecular docking
Abstract |
Fulltext
|
| 39 |
Prediction of novel natural inhibitors of avian coccidia (Eimeria tenella) through molecular docking
Abstract |
Fulltext
|
| 40 |
Molecular docking studies of natural compounds of naringin on enzymes involved in the urea cycle pathway in hyperammonemia
Abstract |
Fulltext
|
| 41 |
Elucidation of the mechanism of action of the anti-cholecystitis effect of the Tibetan medicine “Dida” using network pharmacology
Abstract |
Fulltext
|
| 42 |
Computational and pharmacological evaluation of stevioside derivatives for antinociceptive and anti-inflammatory potential
Abstract |
Fulltext
|
| 43 |
In silico screening of potentially bioactive-anti-functional dyspepsia constituents of Magnoliae officinalis Cortex based on molecular docking and network pharmacology
Abstract |
Fulltext
|
| 44 |
Elucidation of the mechanisms underlying the anti-cholecystitis effect of the Tibetan medicine, Dida, using Network pharmacology
Abstract |
Fulltext
|
| 45 |
Involvement of TNF-alpha and IL-10 in breast cancer and patient survival
Abstract |
Fulltext
|
| 46 |
Anti-proliferative activity of leaves of Launaea capitata Asteraceae: Phytochemical, cytotoxicity and in silico studies
Abstract |
Fulltext
|
| 47 |
In-silico studies of HMG-Co A reductase inhibitors present in fruits of Withania coagulans Dunal (Solanaceae)
Abstract |
Fulltext
|
| 48 |
Excisanin A suppresses proliferation by inhibiting hypoxia-inducible factor-1? expression in human hepatocellular carcinoma cells
Abstract |
Fulltext
|
| 49 |
Substructural dynamics of the phase-I drug metabolizing enzyme, carbonyl reductase 1, in response to various substrate and inhibitor configurations
Abstract |
Fulltext
|
| 50 |
Immunosuppressive effect of voacamine from Voacanga africana Stapf based on SPRi experiment
Abstract |
Fulltext
|
| 51 |
In silico model and design of novel 5α-reductase inhibitors for treatment of benign prostatic hyperplasia
Abstract |
Fulltext
|
| 52 |
In silico screening of anti-inflammatory constituents with good drug-like properties from twigs of Cinnamomum cassia based on molecular docking and network pharmacology
Abstract |
Fulltext
|
| 53 |
Design of dual inhibitors of human TNF-α and IL-6 with potentials for the treatment of rheumatoid arthritis
Abstract |
Fulltext
|
| 54 |
Synthesis, antimicrobial activities and GAPDH docking of novel 1, 2, 3-triazole derivatives
Abstract |
Fulltext
|
| 55 |
Biological screening and docking studies of unique hybrids synthesized by conventional versus microwave-assisted techniques
Abstract |
Fulltext
|
| 56 |
Inhibition of TNF-α and IL-1 by compounds from selected plants for rheumatoid arthritis therapy: In vivo and in silico studies
Abstract |
Fulltext
|
| 57 |
Synthesis, antimicrobial evaluation and docking studies of new pyrazolone derivatives
Abstract |
Fulltext
|
| 58 |
Structural analysis and insight into novel MMP-13 inhibitors from natural chemiome as disease-modifying osteoarthritis drugs
Abstract |
Fulltext
|
| 59 |
In silico elucidation of potential drug target sites of the Thumb Index Fold Protein, Wnt-8b
Abstract |
Fulltext
|
| 60 |
In silico studies on novel inhibitors of MERS-CoV: Structure-based pharmacophore modeling, database screening and molecular docking
Abstract |
Fulltext
|
| 61 |
Investigation of the anti-aging properties of allicin from Allium sativum L bulb extracts by a reverse docking approach
Abstract |
Fulltext
|
| 62 |
In silico design of small molecules targeting cathepsin-k for the treatment of osteoarthritis
Abstract |
Fulltext
|
| 63 |
New N-allylthiourea derivatives: Synthesis, molecular docking and in vitro cytotoxicity studies
Abstract |
Fulltext
|
| 64 |
Molecular docking studies on rocaglamide, a traditional Chinese medicine for periodontitis
Abstract |
Fulltext
|
| 65 |
Synthesis, biological evaluation and molecular docking studies of Mannich bases derived from 1, 3, 4-oxadiazole-2-thiones as potential urease inhibitors
Abstract |
Fulltext
|
| 66 |
Determination of activities of human carbonic anhydrase II inhibitors from curcumin analogs
Abstract |
Fulltext
|
| 67 |
Antiviral evaluation of an Hsp90 inhibitor, gedunin, against dengue virus
Abstract |
Fulltext
|
| 68 |
Synthesis and molecular docking of new hydrazones derived from ethyl isonipecotate and their biological activities
Abstract |
Fulltext
|
| 69 |
Anti-inflammatory effects of kaempferol, myricetin, fisetin and ibuprofen in neonatal rats
Abstract |
Fulltext
|
| 70 |
In-silico design of novel myocilin inhibitors for glaucoma therapy
Abstract |
Fulltext
|
| 71 |
Molecular docking and in silico ADMET studies of silibinin and glycyrrhetic acid anti-inflammatory activity
Abstract |
Fulltext
|
| 72 |
Production of a phage-displayed single chain variable fragment antibody against infectious bursal disease virus
Abstract |
Fulltext
|
| 73 |
Pharmacological evaluation of novel dimers of an arylpropionic acid class of non-selective cyclooxygenase inhibitors
Abstract |
Fulltext
|
| 74 |
Computer-aided discovery of antimicrobial agents as potential enoyl acyl carrier protein reductase inhibitors
Abstract |
Fulltext
|
| 75 |
In-silico investigations into natural products as non-nucleoside DNA methyltransferase 1 inhibitors for treating epi-mutation in gastric cancer
Abstract |
Fulltext
|
| 76 |
Design, synthesis and antiproliferative activity of hydroxyacetamide derivatives against HeLa cervical carcinoma cell and breast cancer cell line
Abstract |
Fulltext
|
| 77 |
S-Alkylated/aralkylated 2-(1H-indol-3-yl-methyl)-1,3,4-oxadiazole-5-thiol derivatives. 2. Anti-bacterial, enzyme-inhibitory and hemolytic activities
Abstract |
Fulltext
|
| 78 |
A holistic in silico approach to develop novel inhibitors targeting ErbB1 and ErbB2 kinases
Abstract |
Fulltext
|
| 79 |
Synthesis, characterization, antimicrobial activity and molecular docking studies of combined pyrazol-barbituric acid pharmacophores
Abstract |
Fulltext
|
| 80 |
Synthesis, crystal structure, density function theory, molecular docking and antimicrobial studies of 2-(3-(4-phenylpiperazin-1-yl) propyl) isoindoline-1,3-dione
Abstract |
Fulltext
|
| 81 |
In vivo and in silico investigation of selected herbal compounds as anti-tubercular agents
Abstract |
Fulltext
|
| 82 |
Application of group-based QSAR and molecular docking in the design of insulin-like growth factor antagonists
Abstract |
Fulltext
|
| 83 |
Hypolipidemic activity of Prosopis cineraria L (Druce) fruit extract and molecular modeling study with farnesoid X receptor (FXR)
Abstract |
Fulltext
|
| 84 |
Molecular Dynamics and Docking of Biphenyl: A Potential Attachment Inhibitor for HIV-1 gp120 Glycoprotein
Abstract |
Fulltext
|
| 85 |
Design and Development of Halogenated Chalcone Derivatives as Potential Anticancer Agents
Abstract |
Fulltext
|
| 86 |
A Novel Mechanistic Approach to Identify New Antifungal Lead Compounds Based on Amphotericin B Molecular Architecture
Abstract |
Fulltext
|
| 87 |
Synthesis, Anticonvulsant Activity and In silco Studies of Schiff Bases of 2-Aminothiophenes via Guanidine-Catalyzed Gewald Reaction
Abstract |
Fulltext
|
| 88 |
Synthesis and Antitubercular Activity of Some Novel Thiazolidinone Derivatives
Abstract |
Fulltext
|
88 matching items found
|
Archives
| 2025; 24: |
1,
2,
3.
|
| 2024; 23: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2023; 22: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2022; 21: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2021; 20: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2020; 19: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2019; 18: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2018; 17: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2017; 16: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2016; 15: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2015; 14: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2014; 13: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2013; 12: |
1,
2,
3,
4,
5,
6.
|
| 2012; 11: |
1,
2,
3,
4,
5,
6.
|
| 2011; 10: |
1,
2,
3,
4,
5,
6.
|
| 2010; 9: |
1,
2,
3,
4,
5,
6.
|
| 2009; 8: |
1,
2,
3,
4,
5,
6.
|
| 2008; 7: |
1,
2,
3,
4.
|
| 2007; 6: |
1,
2,
3,
4.
|
| 2006; 5: |
1,
2.
|
| 2005; 4: |
1,
2.
|
| 2004; 3: |
1.
|
| 2003; 2: |
1,
2.
|
| 2002; 1: |
1,
2.
|
|
